Farbod Darvishian

Summary

Country: USA

Publications

  1. ncbi Concurrent malakoplakia and papillary urothelial carcinoma of the urinary bladder
    F Darvishian
    Department of Pathology, North Shore University Hospital, 300 Community Drive, Manhasset, NY 11030, USA
    Ann Clin Lab Sci 31:147-50. 2001
  2. ncbi Liposarcoma in the bone marrow: a terminal event
    F Darvishian
    Department of Pathology, North Shore University Hospital, Manhasset, New York 11030, USA
    Ann Clin Lab Sci 31:402-4. 2001
  3. ncbi Familial visceral myopathy with carcinoma of unknown primary
    Farbod Darvishian
    Department of Pathology, North Shore University Hospital, Manhasset, New York 11030, USA
    Ann Clin Lab Sci 32:93-7. 2002
  4. ncbi Carcinosarcoma of the pancreas: a case report and review of the literature
    Farbod Darvishian
    Department of Pathology, North Shore University Hospital, Manhasset, NY 11030, USA
    Arch Pathol Lab Med 126:1114-7. 2002
  5. ncbi Atypia on breast core needle biopsies: reproducibility and significance
    Farbod Darvishian
    Department of Pathology, New York University Medical Center, 530 First Avenue SK7N, New York, NY 10016, USA
    Ann Clin Lab Sci 39:270-6. 2009
  6. ncbi Carcinoid tumorlets simulate pulmonary metastases in women with breast cancer
    Farbod Darvishian
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Hum Pathol 37:839-44. 2006
  7. ncbi Immunoreactivity of p16 in anal cytology specimens: histologic correlation
    Farbod Darvishian
    Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Cancer 108:66-71. 2006
  8. ncbi miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis
    Avital Gaziel-Sovran
    Department of Pathology, New York University Medical Center, NY 10016, USA
    Cancer Cell 20:104-18. 2011
  9. ncbi Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy?: a report of 38 cases and review of the literature
    Joan Cangiarella
    Department of Pathology, New York University School of Medicine, New York, USA
    Arch Pathol Lab Med 132:979-83. 2008
  10. ncbi Melanoma MicroRNA signature predicts post-recurrence survival
    Miguel F Segura
    Department of Pathology, New York University School of Medicine, New York, New York, USA
    Clin Cancer Res 16:1577-86. 2010

Collaborators

Detail Information

Publications20

  1. ncbi Concurrent malakoplakia and papillary urothelial carcinoma of the urinary bladder
    F Darvishian
    Department of Pathology, North Shore University Hospital, 300 Community Drive, Manhasset, NY 11030, USA
    Ann Clin Lab Sci 31:147-50. 2001
    ..The biopsy showed a low-grade papillary urothelial carcinoma in close association with malakoplakia. This is a rare association of these lesions...
  2. ncbi Liposarcoma in the bone marrow: a terminal event
    F Darvishian
    Department of Pathology, North Shore University Hospital, Manhasset, New York 11030, USA
    Ann Clin Lab Sci 31:402-4. 2001
    ....
  3. ncbi Familial visceral myopathy with carcinoma of unknown primary
    Farbod Darvishian
    Department of Pathology, North Shore University Hospital, Manhasset, New York 11030, USA
    Ann Clin Lab Sci 32:93-7. 2002
    ..This case shows how a malignant neoplasm can compound the pathology of familial visceral myopathy...
  4. ncbi Carcinosarcoma of the pancreas: a case report and review of the literature
    Farbod Darvishian
    Department of Pathology, North Shore University Hospital, Manhasset, NY 11030, USA
    Arch Pathol Lab Med 126:1114-7. 2002
    ..To our knowledge, this carcinosarcoma is the seventh reported case of a primary pancreatic neoplasm with mixed carcinomatous and sarcomatous elements...
  5. ncbi Atypia on breast core needle biopsies: reproducibility and significance
    Farbod Darvishian
    Department of Pathology, New York University Medical Center, 530 First Avenue SK7N, New York, NY 10016, USA
    Ann Clin Lab Sci 39:270-6. 2009
    ..Strict adherence to the diagnostic criteria and tutorial sessions can help pathologists to achieve substantial agreement in interpreting atypia on breast core needle biopsies...
  6. ncbi Carcinoid tumorlets simulate pulmonary metastases in women with breast cancer
    Farbod Darvishian
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Hum Pathol 37:839-44. 2006
    ..Consideration should be given to the possibility of PCTs in patients with breast cancer with pulmonary nodules, even if multiple...
  7. ncbi Immunoreactivity of p16 in anal cytology specimens: histologic correlation
    Farbod Darvishian
    Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Cancer 108:66-71. 2006
    ..CONCLUSIONS: The presence of p16 immunoreactivity is a good predictor of dysplasia in anal specimens. However, the sensitivity and specificity of this marker are not high...
  8. ncbi miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis
    Avital Gaziel-Sovran
    Department of Pathology, New York University Medical Center, NY 10016, USA
    Cancer Cell 20:104-18. 2011
    ..These data support a key role of miR-30b/30d and GalNAc transferases in metastasis, by simultaneously promoting cellular invasion and immunosuppression...
  9. ncbi Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy?: a report of 38 cases and review of the literature
    Joan Cangiarella
    Department of Pathology, New York University School of Medicine, New York, USA
    Arch Pathol Lab Med 132:979-83. 2008
    ..Due to the debate over the significance of these lesions and the small number of cases reported in the literature, the treatment for lobular neoplasia diagnosed by percutaneous core biopsy (PCB) remains controversial...
  10. ncbi Melanoma MicroRNA signature predicts post-recurrence survival
    Miguel F Segura
    Department of Pathology, New York University School of Medicine, New York, New York, USA
    Clin Cancer Res 16:1577-86. 2010
    ..To identify a melanoma microRNA (miRNA) expression signature that is predictive of outcome and then evaluate its potential to improve risk stratification when added to the standard-of-care staging criteria...
  11. ncbi Langerhans' cell histiocytosis in the parotid gland
    Farbod Darvishian
    Department of Pathology, North Shore University Hospital, Manhasset, NY 11030, USA
    Ann Clin Lab Sci 32:201-6. 2002
    ..There has been no evidence of local recurrence or disease progression during 20 months after the lesion was first diagnosed. Differentiation of Langerhans' cell histiocytosis from Kimura's disease was crucial in this clinical setting...
  12. ncbi The road to discovery of an uncommon tracheobronchial tumor
    Steven I Hajdu
    Department of Pathology, New York University School of Medicine, New York, New York, USA
    Ann Clin Lab Sci 37:375-7. 2007
  13. ncbi Extramedullary hematopoiesis in breast after neoadjuvant chemotherapy for breast carcinoma
    Jun Wang
    Department of Pathology, New York University Medical Center, New York, NY 10016, USA
    Ann Clin Lab Sci 36:475-8. 2006
    ..To our knowledge, the association of EMH and neoadjuvant chemotherapy has not been previously reported...
  14. ncbi Ultrastructural comparison of "alveolar" and "solid" areas in bronchioloalveolar carcinoma
    Farbod Darvishian
    Department of Pathology, North Shore University Hospital, Manhasset, New York 11030, USA
    Ann Clin Lab Sci 32:225-30. 2002
    ..We conclude that the neoplastic cells in bronchioloalveolar carcinoma retain their ultrastructural phenotypes after becoming invasive carcinoma with loss of alveolar differentiation...
  15. ncbi Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases
    Farbod Darvishian
    Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Am J Surg Pathol 28:1568-78. 2004
    ..Our clinical and immunohistochemical data also support the concept that there is a group of endometrial adenocarcinomas composed of tubular glands that are indeed serous carcinomas...
  16. ncbi Myoepithelial cell-rich neoplasms: cytologic features of benign and malignant lesions
    Farbod Darvishian
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 102:355-61. 2004
    ..The authors characterized the cytologic features of myoepithelial cell-rich lesions in an attempt to define the criteria that facilitate distinction between benign and malignant tumors...
  17. ncbi Significance of linear extent of breast carcinoma at surgical margin
    Farbod Darvishian
    Department of Pathology, North Shore University Hospital, Manhasset, New York 11030, USA
    Ann Surg Oncol 10:48-51. 2003
    ..0 cm. CONCLUSIONS: Linear measurement of the inked margin involved by infiltrating mammary carcinoma can be used as a predictor of findings on re-excisions...
  18. ncbi Chromophobe renal cell carcinoma: a clinicopathologic study of 203 tumors in 200 patients with primary resection at a single institution
    Christopher G Przybycin
    Department of Pathology, Urology Service, Memorial Sloan Kettering Cancer Center New York, NY 10065, USA
    Am J Surg Pathol 35:962-70. 2011
    ..On the basis of this long follow-up on a large number of cases, chromophobes seem to have better clinical outcomes than those reported for clear cell and papillary RCCs...
  19. ncbi Intraparenchymal leiomyoma of the breast: a case report and review of the literature
    Lauren Ende
    Dept of Pathology, NYU School of Medicine, New York, NY 10016, USA
    Ann Clin Lab Sci 37:268-73. 2007
    ..In addition, we review the literature on this uncommon breast neoplasm...
  20. ncbi Invasive lobular carcinoma of the breast: role of endothelial lymphatic marker D2-40
    Jordan Laser
    New York University School of Medicine, New York, NY 10016, USA
    Ann Clin Lab Sci 38:99-104. 2008
    ..In conclusion, D2-40 antibody staining may be useful as an adjunct in detecting LVI in invasive lobular carcinoma, especially in node-negative patients with the classic variant of invasive lobular carcinoma...